ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1722

Fate-mapping of Synovial Monocytes and Macrophages

Yidan Wang1, Carla Cuda1, Deborah Winter2 and Harris Perlman1, 1Northwestern University, Chicago, IL, 2Northwestern University, Skokie, IL

Meeting: ACR Convergence 2023

Keywords: genomics, macrophages, Mouse Models, RA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1713–1733) RA – Animal Models Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial monocytes and macrophages are heterogenous populations. These populations play diverse roles in the development of arthritis in humans and mice. In recent years, our laboratory identified a new synovial cell type we named tissue-resident monocyte-lineage cells (TR-MCs), which are are necessary for the development of inflammatory arthritis in mice. Although TR-MCs are CD64 negative and transcriptionally distinct from circulating monocytes and DCs, the current lack of targeted mouse models limit our ability to study this critical population and differentiate from other synovial monocyte and macrophage populations.

Methods: To study each synovial monocyte and macrophage population, we performed fate-mapping with 7 reporter models including Cx3cr1-ERcre-Ai3-YFP, Cx3cr1-Cre-Ai3-YFP, Ms4a3-cre-Ai3-YFP, P2ry12-ERcre-Ai3-YFP, Tmem119-GFP, Cd68-eGFP, and Csf1r-cre-Ai3-YFP in 8–12-week-old C57BL/6 mice. We also further characterized synovial monocyte and macrophage cells by performing cellular indexing of transcriptomes and epitopes (CITE-seq) on synovial macrophages (CD45+CD11b+CD4-CD8-Ly6G-SiglecF-NK1.1-CD64+) and monocytes (CD45+CD11b+CD4-CD8-Ly6G-SiglecF-NK1.1-MHCII-CD64-).

Results: Although 90% of synovial macrophages, 82% NCM and 76% TR-MC are derived from Cx3cr1-positive progenitor cells, only 41%, 91%, 27% of them express Cx3cr1 at 8-12 week-old. Although high percentages of Csf1r-expression were found in almost all synovial cell types, synovial macrophages express the highest intensity of Csf1r. Similarly, Ms4a3 was expressed at a high percentage in both granulocytes and monocyte-lineage cell, but the intensity of Ms4a3 is more than 2 times higher in macrophages than other cell types. P2ry12 was expressed in synovial macrophages and TR-MC with 20% positivity. The expression of CD68 and Tmem119 are same in all synovial myeloid cell types. To develop specific reporter models of synovial monocyte and macrophage subpopulations, we characterize them by merging the 2 CITE-seq datasets and identified 5 synovial macrophages subpopulations – MHCII+ CCL24+ interstitial macrophages, MHCII-CCR2+ interstitial macrophages, Arg1+ macrophages, CD24a+ macrophages and CX3CR1+ synovial lining macrophages as well as TR-MCs, monocyte-lineage cells and polymorphonuclear leukocytes (PMNs). MHCII- CCL24+ interstitial macrophages specifically expressed Cd209d and Ccl24 genes. Arg1+ macrophages exclusively expressed Arg1 and Flt1 genes. The differentially expressed genes of CX3CR1+ synovial lining macrophages are aligned with the CX3XR1+ lining macrophages published by Culemann S, et. al. CD24a+ macrophages highly expressed Tnip3 and Anxa8 genes as well as CD11c surface marker.

Conclusion: Our results currently showed that Cx3cr1, Csf1r, Ms4a3 and P2ry12 may have the ability of tracing one or more synovial monocyte and macrophage populations. The gene and surface markers identified in each synovial monocyte, macrophage and TR-MC population will help develop better tools to trace and delete them. Future studies will also focus on determining the spatial topology of each synovial monocyte and macrophage population to better define their role in joint health.

Supporting image 1

The annotation of the merged CITE-seq datasets of synovial macrophages and monocytes.


Disclosures: Y. Wang: None; C. Cuda: None; D. Winter: Pfizer, 2; H. Perlman: None.

To cite this abstract in AMA style:

Wang Y, Cuda C, Winter D, Perlman H. Fate-mapping of Synovial Monocytes and Macrophages [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/fate-mapping-of-synovial-monocytes-and-macrophages/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fate-mapping-of-synovial-monocytes-and-macrophages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology